Safety and Immunogenicity of Three Influenza Vaccines in Children Aged 4 Years Old to Less Than 18 Years Old

Completed · Phase 3

Conditions studied: Influenza

In brief

Evaluate safety and immunogenicity of three influenza vaccines in children ages greater than 4 years old to less than 18 years old.

Key facts

Study ID
NCT01992107
Run by
Novartis Vaccines
People needed
2333
Starts
2013-11-01
Expected to finish
2014-08-01
Last updated by the study team
2015-12-08

Who can join

Age: 4 and older, up to 18. Sex: any. Healthy volunteers: accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.